Blog
Insights, updates, and stories from the TeselaGen team.
Maximizing Success with Golden Gate Assembly: 4 Things to Look Out For
The manipulation of DNA is an essential task carried out in biotechnological research to precisely edit a given sequence, create artificial genomes, and express recombinant proteins. This article covers four key considerations for optimizing Golden Gate Assembly.
5 Common Challenges in Site-Directed Mutagenesis and How to Overcome Them
Site-directed mutagenesis is a powerful technique that allows scientists to induce changes in genes and study protein structure and function. This article explores five common challenges and strategies to overcome them.
DBTL Cycle Advancements: Software Automation Elevates Biotech R&D Workflows
Exploring the transformative power of the Design-Build-Test-Learn cycle and how software automation is reshaping synthetic biology research and development workflows.
Unlocking the Potential: Strategic Insights on On-Premises and Cloud Hosting
In the rapidly advancing field of biotechnology, effective and secure IP management is not just a necessity — it is a cornerstone of success. This article explores how choosing between on-premises and cloud hosting impacts regulatory compliance and data security.
Using AI to accelerate biotech product development
TeselaGen co-founder and CEO Eduardo Abeliuk shares insights on how artificial intelligence is accelerating biotechnology product development and transforming the industry.
IPI: The Future of AI in Biotechnology
The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms like ChatGPT and Google Bard have dominated headlines as we explore the possibilities for this powerful technology with implications for nearly every industry.
Solving biotech challenges with AI
Biotechnology has enormous potential to solve some of the world's most pressing challenges in health, food security, and the environment. Yet conventional methods for developing biotechnology products rely on slow, trial-and-error processes.
TeselaGen BioTech CEO Eduardo Abeliuk on the Future of AI
Dr. Eduardo Abeliuk shares his perspective on artificial intelligence's potential to drive scientific breakthroughs and transform industries, while addressing concerns about bias, transparency, and the concentration of AI power.
Maximizing Gene Delivery: An Overview of 4 Common Viral Vectors in Gene Therapy and Cell Therapy
Gene therapy is a rapidly evolving research field that aims to treat or cure genetic disorders by replacing, removing, or adding genetic material into cells. This article provides an overview of four common viral vectors used in gene and cell therapy.
Unlocking the Potential of Molecular Cloning: A Look at 5 Popular Plasmids and Their Functions
Plasmids are a crucial tool for molecular cloning in genetic engineering. They are small, circular, double-stranded DNA molecules that can replicate independently within bacterial cells. This article examines five popular plasmids and their functions.
Streamlining Your Lab Operation: The 5 Advantages of Using a LIMS System
Laboratories play a vital role in various industries. Effective laboratory management is crucial for the success of these operations. This article covers five key advantages of using a Laboratory Information Management System.
Open Vector Editor – Circular View Zoom
A long-awaited feature for DNA design: circular view zoom in the Open Vector Editor. This post describes the implementation of this helpful feature for plasmid viewing functionality.
5 Popular Liquid Handling Robots
Highlighting liquid handling robots that assist labs in saving time and resources through integration with TeselaGen's software platform.
The Digitalization of Biotechnology
The digitalization of biotechnology has the potential to accelerate biological discovery. This article explores how digital tools are transforming biotech research and development.
A Conversation with Sarah Richardson – the "Germ Wrangler" (Part II)
Part two of our conversation with Sarah Richardson discusses MicroByre's organism domestication efforts, multidisciplinary approach, and vision for industrial biotechnology.
A Conversation with Sarah Richardson – the "Germ Wrangler" (Part I)
Introducing MicroByre's work addressing societal challenges through biology. A conversation with founder Sarah Richardson about her journey from academia to building a biotech company.
A Conversation with Keith Wilson, CEO of Nalo Therapeutics
Keith Wilson has spent his biopharma career trying to get large molecules to market. This conversation covers his experiences in drug development, from early research and drug discovery through clinical trials.
Growing Synbio Talent in Latin America with iGEM Design League
TeselaGen partners with iGEM to support synthetic biology talent development in Latin America through the Design League competition.
Employee Spotlight: A Conversation with Jota Hurtado
Profiling Jota Hurtado, a Santiago-based TeselaGen team member with software engineering and growth team responsibilities.
Teaching Synthetic Biology to Tomorrow's Scientists
Joshua Heazlewood, Ph.D., revitalized a master's course on Advanced Molecular Biology by incorporating synthetic biology techniques and TeselaGen's cloud-based software for hands-on workshops.
Phycus: Who Said We Had to Put Crude Oil in That?
A conversation with Phycus co-founder and CEO Vik Pandit, Ph.D., about the company's first foray into cosmetics, its partnership with TeselaGen, and its role in the circular economy.
A Better Alternative to npm/yarn Link for Front-End Web Development
Exploring JavaScript development approaches at TeselaGen and a more reliable alternative to npm/yarn link for front-end web development workflows.
Optimizing Fermentation
An exploration of fermentation's central role in bioproducts across pharmaceuticals and industrial biotechnology, and how data-driven approaches can optimize outcomes.
Welcome to TeselaGen Bytes!
Introducing TeselaGen Bytes, our blog dedicated to discussing biotech challenges, the value of data sharing, and how innovations can move to market faster.
Try Tesela AI for free
Design libraries, generate protocols, and optimize experiments with AI agents. No credit card required.